https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
The other 27 non-carcinogenic genotypes had a prevalence of 11.8%, PPV of 2.9% (95% CI2.1-3.9), and OR 1.5 (95% CI 1.1-2.2.) for high-grade cytology. These results suggest that HPV screening tests in the post-vaccination era might perform better if restricted to the HPV types in the nonavalent vaccine and screening for all 14 HPV types might result in suboptimal balance of harms and benefits.Nowadays, as life expectancy grows, the healthcare industry faces growing challenges related to corresponding increases in chronic d
Like
Comment
Share
